SCHEMBL20058376

SCHEMBL20058376

CC(C)(C)OC(=O)N1CCCN(Cc2ccccc2)CC(C)(C)OCC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 6/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ MGLL Q99685 2/20 0.47
▸ CYP3A4 P08684 4/20 0.45
▸ TSHR P16473 4/20 0.45
▸ OPRD1 P41143 1/20 0.44
▸ OPRK1 P41145 1/20 0.44
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ GPR119 Q8TDV5 1/20 0.42
▸ STS P08842 1/20 0.41
▸ USP2 O75604 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18785460 0.87 MGLL (0.58) CYP2D6ALDH1A1MGLLCYP3A4TSHR
SCHEMBL8210703 0.82 KMT2A (0.55) ALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL27045311 0.82 USP2 (0.52) ALDH1A1TSHROPRD1OPRK1MEN1
SCHEMBL17324842 0.81 MGLL (0.70) CYP2D6ALDH1A1MGLLCYP3A4TSHR
SCHEMBL17609058 0.81 CYP2D6 (0.46) CYP2D6ALDH1A1MGLLCYP3A4TSHR
SCHEMBL13115666 0.80 MGLL (0.57) CYP2D6ALDH1A1MGLLCYP3A4TSHR
SCHEMBL19706413 0.80 HPGD (0.49) ALDH1A1TSHROPRD1OPRK1MEN1
SCHEMBL17608910 0.79 CYP2D6 (0.47) CYP2D6ALDH1A1MGLLCYP3A4TSHR
SCHEMBL18785450 0.79 CYP2D6 (0.48) CYP2D6ALDH1A1MGLLCYP3A4TSHR
SCHEMBL17608925 0.79 CHRM2 (0.60) CYP2D6MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3149005-B1 AMIDE DERIVATIVES OF 1-OXA-4,9-DIAZASPIRO UNDECANE COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE LABOR DR (ES) 2018-04-18 — — EP disclosed
Send feedback